Early Safety Assessment - Drug Discovery and Development Based on

The drug candidate faces numerous efficacy and safety hurdles before moving forward to clinical testing. Here at the UPDDI we recognize the need for early identification of potential human toxicity and pharmacokinetic issues by creating a unique human liver microphysiological systems  platform for drug testing before implementing preclinical animal testing.

Exploring different approaches to improve the success of drug

Moving Preclinical Safety Evaluation from Hazard Identification

Phases of Drug Development Process, Drug Discovery Process

AN OVERVIEW OF NEW DRUG DISCOVERY AND DEVELOPMENT

Biomarkers in efficacy and safety assessments. Application of in

Drug development – The four phases - BioStock

Principles of early drug discovery - Hughes - 2011 - British

PDF] In silico Toxicology-A Tool for Early Safety Evaluation of

From Bench to Clinic - The Chronology of Preclinical Studies - ITR

Which Human Metabolites Have We MIST? Retrospective Analysis